Berlin - Delayed Quote EUR

Heron Therapeutics Inc (AXD2.BE)

Compare
1.9050
-0.0480
(-2.46%)
As of 5:20:03 PM GMT+2. Market Open.
Loading Chart for AXD2.BE
  • Previous Close 1.9530
  • Open 1.9270
  • Bid 1.8340 x --
  • Ask 1.9570 x --
  • Day's Range 1.8730 - 1.9270
  • 52 Week Range 1.0320 - 3.6140
  • Volume 0
  • Avg. Volume 23
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: AXD2.BE

View More

Performance Overview: AXD2.BE

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

AXD2.BE
30.39%
S&P 500 (^GSPC)
12.18%

1-Year Return

AXD2.BE
20.95%
S&P 500 (^GSPC)
0.36%

3-Year Return

AXD2.BE
66.72%
S&P 500 (^GSPC)
12.72%

5-Year Return

AXD2.BE
82.03%
S&P 500 (^GSPC)
107.56%

Compare To: AXD2.BE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AXD2.BE

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    298.93M

  • Enterprise Value

    407.58M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.25

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    3.08

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: AXD2.BE

View More

Company Insights: AXD2.BE

Research Reports: AXD2.BE

View More